No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

NeuroLogica’s OmniTom® Elite CT Scanner Now Available – See it at RSNA 2021

Editor: What To Know

  • “The OmniTom Elite's ability to provide versatile, real-time mobile imaging enables healthcare providers to administer point-of-care CT to critical patients without the need to transport them to a separate department,” said David Webster, Chief Operating Officer of NeuroLogica.
  • “It is truly a facility-wide solution that decreases the time it takes to diagnose and initiate treatment for patients in need of care.
  • Battery operated and chargeable in a standard wall outlet, allows for continued use throughout the facility.

NeuroLogica’s next-generation multi-slice, small-bore, mobile OmniTom® Elite, which delivers high-quality point-of-care CT imaging, is released for sale in the USA.

“The OmniTom Elite’s ability to provide versatile, real-time mobile imaging enables healthcare providers to administer point-of-care CT to critical patients without the need to transport them to a separate department,” said David Webster, Chief Operating Officer of NeuroLogica. “It is truly a facility-wide solution that decreases the time it takes to diagnose and initiate treatment for patients in need of care.”

Expanding on the benefits of its predecessor, the OmniTom Elite includes:

  • Improved omni-wheel design contributes to durability through transport as well as 360-degree mobility
  • An integrated drive system with drive camera and audio/visual sensors facilitates unimpeded movement through the facility
  • SmartAlign auto-alignment feature streamlines scanner-to-patient bed alignment which is instrumental in restricted spaces
  • Battery operated and chargeable in a standard wall outlet, allows for continued use throughout the facility
  • Integrated shielding to increase durability and protect staff
  • An ergonomic design with wireless tablet control designed with a single user in mind
  • Mobile Stroke Unit configuration, for use with emergency vehicles

In addition to the OmniTom Elite, NeuroLogica will also be showcasing its BodyTom 64 (510k pending) large bore scanner; the first ever mobile 64 slice whole body CT.

More on their visibility at RSNA can be found here.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

VeraClinic: Pioneering Personal Transformation Through Hair Transplantation and Cosmetic Surgery in Turkey

As a testament to Turkey's legacy in the world of aesthetic medicine, VeraClinic invites you to discover the transformative power of our hair transplantation and cosmetic surgery services.

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy